Kellner Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Kellner Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-44,700	Closed	-$1.07M	–	39
2021 Q1	$1.07M	Buy	+44,700	New	+$831K	0.39%	30

Kellner Capital's GNMK Position: Q2 2021 in Review

Kellner Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 44,700 shares — an estimated $1.07M sold.

Kellner Capital first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1.07M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Kellner Capital reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Kellner Capital sold 44,700 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.07M.
Kellner Capital first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Kellner Capital's GenMark Diagnostics, Inc position peaked at $1.07M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Kellner Capital's 13F filing for Q2 2021, filed 9 Aug 2021.